#14 Biofilm Pathology Assessment and Management

$0.00

This is a product page for purchasing this course. To go to the course page click here

1.5 CE Total | 1.0 Pharm

Biofilm research has expanded greatly in the recent decade. Biofilms are the cause of a great deal of drug and treatment resistant infections and morbidity / mortality. In this course we will look at the spectrum of biofilm formation from normal to pathogenic. We will assess evidence-based therapies as well.

 

SKU: NAEMCDAMonthlyWebinar#14 Category:

Description

This is a product page for purchasing this course. To go to the course page click here

Abstract

Biofilm research has expanded greatly in the recent decade. Biofilms are the cause of a great deal of drug and treatment resistant infections and morbidity / mortality. In this course we will look at the spectrum of biofilm formation from normal to pathogenic. We will assess evidence-based therapies as well.

Learning Objectives:

  • Define Biofilms of normal versus Phase-1 and Phase-2 pathogenicity
  • Describe biofilm contribution to drug resistance
  • Describe biofilm prevention
  • Describe drug and natural therapeutics

There are no reviews yet.

Be the first to review “#14 Biofilm Pathology Assessment and Management”